ロード中...
Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
INTRODUCTION: In the last decades, the therapeutic decision-making approach to metastatic renal cell cancer (mRCC) has dramatically changed thanks to the introduction in the treatment scenario of, first, anti-angiogenic agents and, afterward, immune-checkpoint inhibitors (ICIs). Immunotherapy is now...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7434861/ https://ncbi.nlm.nih.gov/pubmed/32903369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01644 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|